Simons Trading Research

Singapore Exchange - Platform Play

simonsg
Publish date: Sun, 24 Jan 2021, 10:05 AM
simonsg
0 3,868
Simons Stock Trading Research Compilation

Resilient Platform Poised to Deliver Amidst Volatility

  • SGX (SGX:S68)’s 1H21 PAT came ahead of Street/MKE expectations supported by contributions from recent acquisitions and stronger cash equities volumes.
  • Derivatives saw limited disruption from the departure of key contracts pointing to the resilience of its multi-asset platform. Higher contract pricing, strong equity market velocity and new product launches should continue to support earnings momentum and keep dividend visibility high, in our view.
  • We raise our target price to S$11.48 from S$10.77. Maintain BUY.

Acquisitions Delivering

  • The integration of BidFX and Scientific Beta contributed 6% of SGX's revenues in 1H21. Strengthening demand for fixed income listings together with new product launches – especially in the ESG space – should continue to drive growth going forward, we believe.
  • Management claims they are willing to leverage SGX’s balance sheet (current debt-to-equity 9.6%) for further accretive acquisitions. This should be a positive catalyst, given their track record so far.

Tailwind From Cash Equities, Derivatives

  • Derivative volumes increased 4% y-o-y despite the exit of key MSCI contracts. The newly introduced FTSE contracts seem to be gaining traction. SGX’s ability to retain liquidity here is a strong indicator of the successful execution of its multi-asset platform. While derivative fees fell 5% y-o-y on the back of introductory pricing for the new FTSE contracts, we expect this to normalise in 2H21.
  • Separately, cash equity average daily traded value (ADV) increased 19% y-o-y and velocity rose to 49% (~34%). Clearing fees increased 2.5% y-o-y driven by a larger retail mix, we believe. Liquidity support by central banks and the COVID-19 recovery theme could continue to support this momentum, in our view.
  • We have raised our FY21 average daily value (ADV) forecasts to S$1.3bn (from S$1.0bn).

Raise SGX Target Price to S$11.48. Maintain BUY

  • Our changes to equity and derivative volumes and fee expectations have raised FY21-23E PAT by 1-7%. We refresh our blended multi-stage DCF (WACC 7.2%, 1% terminal growth) and peer P/E (upgraded to 29x target) price to S$11.48.
  • In past growth cycles, SGX's share price has traded up to 26-27x P/E.

Source: Maybank Kim Eng Research - 24 Jan 2021

Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment